Cargando…
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
The current treatment paradigm for prolactinomas involves dopamine agonist (DA) therapy as the first-line treatment, with surgical resection reserved for cases where there is DA failure due to resistance or intolerance. This review highlights how DA therapy can be optimised to overcome its increasin...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259306/ https://www.ncbi.nlm.nih.gov/pubmed/37435462 http://dx.doi.org/10.1530/EO-21-0038 |